The formatting of Agner R. Parra Sánchez’s name in the xml was incorrect, resulting in Parra being wrongly classed as a middle name. This has now been corrected on the web.

Tell your doctor Should you be pregnant or system to become pregnant. You shouldn't turn out to be pregnant though working with bortezomib. Bortezomib could harm an unborn baby. Your health care provider ought to get a pregnancy examination Before you begin this medication. Ladies utilizing this medication should really question about trustworthy varieties of start Manage all through procedure and for 7 months following the very last dose.

To prevent dehydration, it is crucial to consume a lot of fluids when you are currently being treated with this particular drug. Talk to your doctor or pharmacist When you have any inquiries.

lopinavir will enhance the amount or result of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.

used to declare that two businesses Doing work collectively or merging can attain in excess of when they perform independently:

itraconazole will improve the amount or result of bortezomib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

larotrectinib will raise the stage or effect of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Not known.

bortezomib will increase the stage or impact of oliceridine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Keep an Ritobegron HCl eye on Carefully. If concomitant use is necessary, could have to have less frequent oliceridine dosing.

In the meantime, to ensure ongoing help, we've been displaying the site without the need of kinds and JavaScript.

erythromycin lactobionate will boost the level or outcome of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

cyclophosphamide will improve Lenvatinib the amount or impact of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.

Bortezomib is FDA-accredited to be used within the First treatment of Thromboxane B2 a number of myeloma in combination with cyclophosphamide and dexamethasone. Additionally it is FDA-approved for use while in the treatment of a number of myeloma in people who Beforehand responded to bortezomib and relapsed a minimum of six months after the completion on the prior procedure.

Speak with your physician about feeding on grapefruit and ingesting grapefruit juice although working with this medication.

Indicated for therapy of people with mantle cell lymphoma as initially-line in Formerly untreated people or all those who have relapsed